Clinical Trials: Seeking Female Diversity
Published : 2016-05-03
Author : USAGov - Contact: usa.gov
Synopsis* : It is important for more women, particularly those of diverse ethnicities, to take part in clinical trials.
Everyone celebrates when a new medication or experimental treatment cures a friend or family member. New drugs and other medical advancements are the result of years of study in clinical trials conducted by medical researchers and doctors.
It takes a wide range of participants to volunteer to test the safety and effectiveness of new drugs or medical products. Formerly, medical diagnoses, treatments, and preventive measures came from clinical trials that were conducted only on men. But medical products and treatments can affect men and women differently, so it's important for more women, particularly those of diverse ethnicities, to take part in clinical trials to continue the progress.
By including this underrepresented population, healthcare providers can learn how to tailor care and improve the health of diverse women today and in the future. Getting feedback from different groups can also help the Food and Drug Administration (FDA) address any concerns about a new test, drug, or product before moving forward with the results.
If you're thinking of participating in a clinical trial or learning more about them, check out these four recommendations from the FDA Office of Women's Health to get started. And always discuss any issues, risks, or potential benefits with your doctor before participating in a clinical trial.
Learn about the purpose of the trial and consider your availability before you commit.
Ask the medical researchers about the details of the clinical trial, including the purpose of the study and the type of drugs, tests, or treatment you will receive. Participating could be time consuming, so consider your availability.
Consider the possible benefits and risks.
The treatment you receive in the clinical trial may help your medical condition. But it's also possible that you may not get any direct benefit from participating. You may experience side effects from the treatment, and if you get a placebo medication, you may not be receiving the actual drug being tested at all. Keep your options open, and consider any other treatments for people with your medical condition.
Be aware of possible costs to you.
Some clinical trials are free or offer compensation for participants, but others may require you or your insurance to pay for treatments or services that are part of the study. Be sure you know the financial details before you sign up.
Don't be afraid to ask questions.
Ask the medical researchers or sponsors everything you need to know to decide whether the clinical trial is right for you. Remember to ask about the privacy of your personal and medical information, who you should contact if you have questions or problems during the clinical trial, and how to say no or opt out even after the clinical trial has started.
Learn more about women in clinical trials and read personal stories of women who participated in clinical trials. Search for publicly and privately supported clinical studies in clinicaltrials.gov
Find more tools and health tips from USAGov, your guide to government information and services at USA.gov/explore.
USAGov is a federal program that guides you to tips and tools in English and in Spanish from hundreds of government agencies, departments, and programs. We make it easier for you to find answers you can trust about government information and services - online, by phone, e-mail or chat, and in print.
You're reading Disabled World. Be sure to check out our homepage for further informative disability news, reviews, disability sports events, exclusive stories and how-tos. You can also find us on Twitter, Facebook, and LinkedIn.
Related Clinical Trials Documents
- 1: IMC-1 Fibromyalgia Treatment Reduces Pain and Symptoms : IMC-1 oral medication proves highly effective at reducing pain and other symptoms of fibromyalgia (FM) in patients in a recent clinical trial.
- 2: Pain Relief for Knee Osteoarthritis with Traumeel and Zeel Intra-articular Injections : This study supports clinical feedback from healthcare professionals regarding positive outcomes with Traumeel and Zeel injections in knee osteoarthritis.
- 3: FDA Grants Therapy Designation for Ocrelizumab in Primary Progressive MS : FDA grants breakthrough therapy designation for the investigational medicine Ocrelizumab (OCREVUS) for treatment of primary progressive multiple sclerosis (PPMS).
- 4: New Multiple Sclerosis Treatment Clinical Trial Begins Enrollment : Clinical trial of Autologous Hematopoietic Stem Cell Transplantation versus Best Available Therapy for Multiple Sclerosis (BEAT-MS) begins enrollment.
- 5: Pediatric Neural Tumor Shrinkage Shown in Selumetinib Clinical Trial : Early-phase clinical trial of selumetinib in children with common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas.
*Disclaimer: Disabled World provides general information only. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World. View our Advertising Policy for further information. Please report outdated or inaccurate information to us.
Journal: Disabled World. Language: English (U.S.). Author: USAGov. Electronic Publication Date: 2016-05-03. Title: Clinical Trials: Seeking Female Diversity, Source: <a href=https://www.disabled-world.com/medical/clinical-trials/fd.php>Clinical Trials: Seeking Female Diversity</a>. Retrieved 2021-04-16, from https://www.disabled-world.com/medical/clinical-trials/fd.php - Reference: DW#340-12147.